Tech Company Financing Transactions

Anodyne Nanotech Funding Round

Anodyne Nanotech closed a $12.6 million Series A financing round on 6/24/2026. Backers included Evercurious VC, Velocity Equity Partners and Relativity Healthcare Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

38 Wareham St. 3rd Floor
Boston, MA 02118
USA

Phone

(732) 503-3865

Website

www.theheropatch.com

Email Address

[email protected]

Overview

Anodyne is a preclinical-stage biotech company developing differentiated, transdermal forms of high-value drugs. The company's patent-pending, porous microneedle technology provides the first practical and cost-effective platform, Hero Patch, to deliver clinically meaningful doses of macromolecules (such as monoclonal antibodies) or small molecules (such as ibuprofen) for fast and sustained delivery.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jake Lombardo

        

Chief Technical Officer

Hojat Nejad

        

VP - Bus. Development

Konstantinos Tzortzakis

        

Browse more venture capital transactions:

Prev: 6/24/2026: Anchorbase venture capital transaction
Next: 6/24/2026: Ollin Biosciences venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary